R

ReShape Lifesciences
D

RSLS

5.17000
USD
-0.36
(-6.51%)
Pre Open
Volume
298
EPS
0
Div Yield
0
P/E
0
Market Cap
2,619,510
Related Instruments
    A
    AIH
    0
    (0%)
    0.000000 USD
    F
    FREQ
    0
    (0%)
    0.000000 USD
    I
    IRTC
    -2.230
    (-2.59%)
    84.030 USD
    K
    KNSA
    -0.870
    (-3.27%)
    25.730 USD
    MRNA
    -25.020
    (-20.99%)
    94.160 USD
    O
    ONTX
    0
    (0%)
    0.000000 USD
    P
    PSTV
    0.00000
    (0.00%)
    1.80000 USD
    Z
    ZNTL
    -0.08000
    (-2.06%)
    3.81000 USD
    More
News

Title: ReShape Lifesciences Inc

Sector: Healthcare
Industry: Medical Devices
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.